Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: €2.21 M
• Last 3 months FTD volume: €29.33 M
• Last year FTD volume: €29.33 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	€48.74 M	€0.23 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	€20.22 M	€45.29 M	🇺🇸 USA
AbbVie ABBV	€75.4 M	€0.15 B	🇺🇸 USA
Illumina ILMN	€43.22 M	€71.6 M	🇺🇸 USA
Biogen BIIB	€7.66 M	€69.08 M	🇺🇸 USA
Pfizer PFE	€50.21 M	€0.38 B	🇺🇸 USA
Johnson & Johnson JNJ	€70.18 M	€0.32 B	🇺🇸 USA
Eli Lilly LLY	€41.73 M	€0.14 B	🇺🇸 USA
Merck MRK	€14.45 M	€88.44 M	🇺🇸 USA